Ropinirole treatment for restless legs syndrome
- PMID: 18312162
- DOI: 10.1517/14656566.9.4.611
Ropinirole treatment for restless legs syndrome
Abstract
Background: Restless legs syndrome (RLS) is a chronic neurological disorder associated with sleep disturbance.
Objective: Prepare a drug evaluation of the non-ergot dopamine agonist ropinirole in RLS.
Methods: Review of scientific literature on RLS, particularly focusing on treatment with ropinirole.
Conclusion: Ropinirole has been studied for treatment of moderate to severe primary RLS in a comprehensive clinical development program. Ropinirole significantly improved symptoms of RLS, versus placebo, in patients with primary RLS. These improvements are supported by data from individual studies and pooled analyses. Significant improvements in RLS symptoms were observed within two nights of treatment. Ropinirole also produced significant benefits on objective measures of RLS motor symptoms, such as periodic leg movements, and subjective measures of sleep. Ropinirole was generally well tolerated.
Similar articles
-
Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.Curr Med Res Opin. 2006 Oct;22(10):1867-77. doi: 10.1185/030079906X132442. Curr Med Res Opin. 2006. PMID: 17022844
-
Ropinirole treatment for restless legs syndrome.Expert Opin Drug Metab Toxicol. 2008 May;4(5):655-64. doi: 10.1517/17425255.4.5.655. Expert Opin Drug Metab Toxicol. 2008. PMID: 18484922 Review.
-
Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.Sleep Med. 2005 Mar;6(2):141-7. doi: 10.1016/j.sleep.2004.12.002. Sleep Med. 2005. PMID: 15716217 Clinical Trial.
-
Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.Sleep Med. 2008 Dec;9(8):899-902. doi: 10.1016/j.sleep.2007.08.017. Epub 2007 Nov 19. Sleep Med. 2008. PMID: 18024167 Clinical Trial.
-
Ropinirole in the treatment of restless legs syndrome.Expert Rev Neurother. 2005 Jan;5(1):35-42. doi: 10.1586/14737175.5.1.35. Expert Rev Neurother. 2005. PMID: 15853472 Review.
Cited by
-
The effect of ropinirole on the quality of life in patients with restless legs syndrome in Korea: an 8-week, multicenter, prospective study.J Clin Neurol. 2013 Jan;9(1):51-6. doi: 10.3988/jcn.2013.9.1.51. Epub 2013 Jan 3. J Clin Neurol. 2013. PMID: 23346161 Free PMC article.
-
Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice.Hum Mol Genet. 2012 Sep 15;21(18):3984-92. doi: 10.1093/hmg/dds221. Epub 2012 Jun 7. Hum Mol Genet. 2012. PMID: 22678064 Free PMC article.
-
Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets.Curr Med Chem. 2008;15(24):2456-71. doi: 10.2174/092986708785909094. Curr Med Chem. 2008. PMID: 18855673 Free PMC article. Review.
-
Developing an Improved UHPLC Method for Efficient Determination of European Pharmacopeia Process-Related Impurities in Ropinirole Hydrochloride Using Analytical Quality by Design Principles.Molecules. 2020 Jun 10;25(11):2691. doi: 10.3390/molecules25112691. Molecules. 2020. PMID: 32531959 Free PMC article.
-
An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy.Int J Mol Sci. 2023 May 11;24(10):8580. doi: 10.3390/ijms24108580. Int J Mol Sci. 2023. PMID: 37239927 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
